These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10613922

  • 1. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.
    Kunath K, Kopecková P, Minko T, Kopecek J.
    Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.
    Minko T, Kopecková P, Kopecek J.
    Pharm Res; 1999 Jul; 16(7):986-96. PubMed ID: 10450921
    [Abstract] [Full Text] [Related]

  • 5. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
    Omelyanenko V, Gentry C, Kopecková P, Kopecek J.
    Int J Cancer; 1998 Feb 09; 75(4):600-8. PubMed ID: 9466663
    [Abstract] [Full Text] [Related]

  • 6. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line.
    Minko T, Kopecková P, Kopecek J.
    J Control Release; 1999 May 20; 59(2):133-48. PubMed ID: 10332049
    [Abstract] [Full Text] [Related]

  • 7. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro.
    Omelyanenko V, Kopecková P, Gentry C, Shiah JG, Kopecek J.
    J Drug Target; 1996 May 20; 3(5):357-73. PubMed ID: 8866655
    [Abstract] [Full Text] [Related]

  • 8. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
    Lu JM, Peterson CM, Guo-Shiah J, Gu ZW, Peterson CA, Straight RC, Kopecek J.
    Int J Oncol; 1999 Jul 20; 15(1):5-16. PubMed ID: 10375588
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
    Shiah JG, Sun Y, Peterson CM, Straight RC, Kopecek J.
    Clin Cancer Res; 2000 Mar 20; 6(3):1008-15. PubMed ID: 10741728
    [Abstract] [Full Text] [Related]

  • 10. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.
    Hongrapipat J, Kopecková P, Liu J, Prakongpan S, Kopecek J.
    Mol Pharm; 2008 Mar 20; 5(5):696-709. PubMed ID: 18729468
    [Abstract] [Full Text] [Related]

  • 11. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
    Shiah JJ, Sun Y, Peterson CM, Kopecek J.
    J Control Release; 1999 Aug 27; 61(1-2):145-57. PubMed ID: 10469911
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.
    Tijerina M, Kopecková P, Kopecek J.
    Photochem Photobiol; 2003 Jun 27; 77(6):645-52. PubMed ID: 12870851
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates.
    Kasuya Y, Lu ZR, Kopecková P, Minko T, Tabibi SE, Kopecek J.
    J Control Release; 2001 Jul 06; 74(1-3):203-11. PubMed ID: 11489496
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.
    Minko T, Kopecková P, Kopecek J.
    Int J Cancer; 2000 Apr 01; 86(1):108-17. PubMed ID: 10728603
    [Abstract] [Full Text] [Related]

  • 15. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
    Kovár M, Strohalm J, Etrych T, Ulbrich K, Ríhová B.
    Bioconjug Chem; 2002 Apr 01; 13(2):206-15. PubMed ID: 11906257
    [Abstract] [Full Text] [Related]

  • 16. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance.
    Tijerina M, Fowers KD, Kopecková P, Kopecek J.
    Biomaterials; 2000 Nov 01; 21(21):2203-10. PubMed ID: 10985494
    [Abstract] [Full Text] [Related]

  • 17. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice.
    Peterson CM, Lu JM, Sun Y, Peterson CA, Shiah JG, Straight RC, Kopecek J.
    Cancer Res; 1996 Sep 01; 56(17):3980-5. PubMed ID: 8752167
    [Abstract] [Full Text] [Related]

  • 18. Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes.
    Omelyanenko V, Kopecková P, Prakash RK, Ebert CD, Kopecek J.
    Pharm Res; 1999 Jul 01; 16(7):1010-9. PubMed ID: 10450924
    [Abstract] [Full Text] [Related]

  • 19. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
    Searle F, Gac-Breton S, Keane R, Dimitrijevic S, Brocchini S, Sausville EA, Duncan R.
    Bioconjug Chem; 2001 Jul 01; 12(5):711-8. PubMed ID: 11562189
    [Abstract] [Full Text] [Related]

  • 20. Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
    Lu ZR, Kopecková P, Kopecek J.
    Nat Biotechnol; 1999 Nov 01; 17(11):1101-4. PubMed ID: 10545917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.